CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 35 filers reported holding CARDIOME PHARMA CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $1,000 | – | 504 | 0.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 504 | -49.8% | 0.00% | – |
Q3 2017 | $2,000 | -50.0% | 1,004 | +25.5% | 0.00% | – |
Q2 2017 | $4,000 | -80.0% | 800 | -88.2% | 0.00% | – |
Q1 2017 | $20,000 | +11.1% | 6,752 | 0.0% | 0.00% | – |
Q4 2016 | $18,000 | -18.2% | 6,752 | 0.0% | 0.00% | – |
Q3 2016 | $22,000 | -35.3% | 6,752 | 0.0% | 0.00% | – |
Q2 2016 | $34,000 | +30.8% | 6,752 | +4.6% | 0.00% | – |
Q1 2016 | $26,000 | -50.9% | 6,452 | -1.9% | 0.00% | – |
Q4 2015 | $53,000 | +960.0% | 6,577 | +915.0% | 0.00% | – |
Q3 2015 | $5,000 | -50.0% | 648 | -35.9% | 0.00% | – |
Q2 2015 | $10,000 | 0.0% | 1,011 | -0.5% | 0.00% | – |
Q1 2015 | $10,000 | 0.0% | 1,016 | -0.6% | 0.00% | – |
Q4 2014 | $10,000 | +11.1% | 1,022 | -0.8% | 0.00% | – |
Q3 2014 | $9,000 | +125.0% | 1,030 | +106.0% | 0.00% | – |
Q2 2014 | $4,000 | 0.0% | 500 | -3.8% | 0.00% | – |
Q1 2014 | $4,000 | +33.3% | 520 | +4.0% | 0.00% | – |
Q4 2013 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | – |
Q3 2013 | $2,000 | +100.0% | 500 | -26.5% | 0.00% | – |
Q2 2013 | $1,000 | – | 680 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Renaissance Technologies | 528,913 | $1,227,000 | 0.00% |